Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
William J. Sandborn
Sign up to set email alerts
2,611
Publications
118,736
Citation Statements Received
34,514
Citation Statements Given
How they've been cited
168,364
3,596
114,570
570
How they cite others
52,908
1,262
33,079
173
Affiliations
University of California, San Diego
,
Mayo Clinic
Publications
Order By: Most citations
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts
1
,
Sandborn
2
,
Feagan
3
et al.
2005
N Engl J Med
3,877
75
2,921
11
3
Get access via publisher
Add to collection
Cite
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Turner
1
,
Ricciuto
2
,
Lewis
3
et al.
2021
Gastroenterology
Abstract
Show
2,996
46
2,876
3
Get access via publisher
Add to collection
Cite
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan
1
,
Rutgeerts
2
,
Sands
3
et al.
2013
N Engl J Med
Abstract
Show
2,929
70
2,330
11
Get access via publisher
Add to collection
Cite
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Colombel
1
,
Sandborn
2
,
Reinisch
3
et al.
2010
N Engl J Med
Abstract
Show
3,119
72
2,168
19
Get access via publisher
Add to collection
Cite
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn
1
,
Feagan
2
,
Rutgeerts
3
et al.
2013
N Engl J Med
Abstract
Show
2,734
61
1,880
6
Get access via publisher
Add to collection
Cite
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Feagan
1
,
Sandborn
2
,
Gasink
3
et al.
2016
N Engl J Med
1,900
55
1,601
7
Get access via publisher
Add to collection
Cite
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn
1
,
Su
2
,
Sands
3
et al.
2017
N Engl J Med
Abstract
Show
1,817
36
1,578
4
Get access via publisher
Add to collection
Cite
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
Peyrin‐Biroulet
1
,
Sandborn
2
,
Sands
3
et al.
2015
Abstract
Show
1,892
16
1,587
2
Get access via publisher
Add to collection
Cite
1
2
3
4